-
1
المصدر: Netherlands Heart Journal. 24(4):252-258
مصطلحات موضوعية: NT-PROBNP, BODY-COMPOSITION, PHOSPHODIESTERASE-5 INHIBITION, Heart failure, DIASTOLIC DYSFUNCTION, Preserved ejection fraction, GROWTH-DIFFERENTIATION FACTOR-15, Prognosis, EXERCISE CAPACITY, PROGNOSTIC VALUE, BRAIN NATRIURETIC PEPTIDE, CLINICAL STATUS, Diagnosis, I-PRESERVE, Natriuretic peptides, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=dris___01423::1d41b6f23797e6bf0208220a31d896d2Test
https://doi.org/10.1007/s12471-016-0817-7Test -
2
المؤلفون: Wouter C. Meijers, A. R. Van der Velde, R. A. De Boer
المصدر: Netherlands Heart Journal
مصطلحات موضوعية: NT-PROBNP, medicine.medical_specialty, BODY-COMPOSITION, medicine.drug_class, Developing heart, PHOSPHODIESTERASE-5 INHIBITION, Heart failure, Review Article, 030204 cardiovascular system & hematology, EXERCISE CAPACITY, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Diagnosis, medicine, Natriuretic peptide, I-PRESERVE, Natriuretic peptides, 030212 general & internal medicine, Ejection fraction, business.industry, DIASTOLIC DYSFUNCTION, Preserved ejection fraction, GROWTH-DIFFERENTIATION FACTOR-15, Prognosis, medicine.disease, Brain natriuretic peptide, PROGNOSTIC VALUE, Clinical trial, BRAIN NATRIURETIC PEPTIDE, CLINICAL STATUS, Cardiology, GDF15, Cardiology and Cardiovascular Medicine, Heart failure with preserved ejection fraction, business, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf9471c3089b51424e6f8cb0034af9a8Test
https://doi.org/10.1007/s12471-016-0817-7Test